Stock screenerAll disclosures →
EDGAR →
ORGO
Conviction 0HealthcareScan · Thu, Jun 25, 2026ORGO$2.42-0.82%
ResistanceSupportVol 14Vol MA14 690.05K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price2.42
Change-0.82%
Gap+0.00%
Rel volume0.89×
Avg volume798.53K
Avg $ vol1.94M
SMA 202.42
SMA 502.46
SMA 2003.70
Price vs 50-1.79%
Price vs 200-34.66%
MA stackbearish
50/200 cross—
Supertrendup · 2.17
RSI (14)48
MACD hist0.00
MACD crossbull · 2d
Stoch %K / %D42 / 50
ADX (14)9
+DI / −DI22 / 22
RSI divergence—
MACD divergence—
ATR %+5.51%
ADR %5.23%
52w high6.54
52w low2.24
From 52w high-63.00%
Above 52w low+8.04%
New 52w highNo
SqueezeOn · 2d
Bollinger width13.52%
%B0.50
Donchian pos48.19%
Donchian high2.68
Donchian low2.18
AVWAP (52w high)3.52
vs AVWAP high-31.33%
AVWAP (52w low)2.47
vs AVWAP low-2.04%
OBV trendDown
Chaikin MF (20)-0.05
Today vs 20d0.89×
Avg vol (14d)690.05K
Avg vol (20d)798.53K
Avg $ vol (20d)1.94M
Market cap311.39M
RS 3m (vs SPY)-11.01%
RS 6m (vs SPY)-64.16%
RS line new highNo
Trend template0/8
Technical rank16.6
1 week+3.42%
1 month-9.02%
3 months-0.82%
6 months-57.62%
1 year-30.06%
YTD-47.79%
P/E8.41
P/B1.27
P/S0.55
P/FCF-12.73
EPS0.1500
Div yield—
ROE15.14%
ROA7.12%
Debt/Eq0.20
Current3.53
EV/EBITDA4.50
Gross margin64.93%
Net margin6.56%
Rev growth17.04%
EPS growth4201.05%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value269.65M
Revenue37.23M
Net income-53.16M
Gross profit62.97M
Free cash flow-24.46M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out128.67M
Employees854
ListedTue, Nov 29, 2016
Free float71.94M
Float %55.9%
Short interest13.3M
Days to cover11.6d
Short volume60.3%
Squeeze score76 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank16.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.76
Support2.11
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ORGO
No recent disclosed trades by Congress in ORGO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ORGO · 1 buy · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Grow Brian Chief Commercial Officer · Class A Common Stock · 2025-01-10 | Exercise | 958 | $1K | 2025-01-10 | 2026-04-24 |
Grow Brian Chief Commercial Officer · Stock Option (Right to Buy) · 2025-01-10 | Exercise | 958 | $0 | 2025-01-10 | 2026-04-24 |
SEC filings
EDGAR filings in ORGO · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.